Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge

Cancer

Volumn 101, Issue 3, 2004, Pages 508-517

  Cabioglu, Neslihan ^a   Krishnamurthy, Savitri ^a   Kuerer, Henry M ^a   Hunt, Kelly K ^a   Singletary, S Eva ^a   Meric Bernstam, Funda ^a   Ross, Merrick I ^a   Feig, Barry W ^a   Ames, Frederick C ^a   Babiera, Gildy V ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast carcinoma; Breast conserving surgery; Nipple discharge; Nipple discharge cytology; Nipple involvement; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; BREAST AREOLA; BREAST CARCINOMA; BREAST CONSERVING SURGERY; BREAST DISCHARGE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CONFIDENCE INTERVAL; CYTOLOGY; DISEASE ASSOCIATION; FEASIBILITY STUDY; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL RECORD; METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SAFETY; SEGMENTAL MASTECTOMY;

ADULT; AGE DISTRIBUTION; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NIPPLES; PAGET'S DISEASE, MAMMARY; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 3242759894     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20394     Document Type: Review

References (32)

1. Leis HP Jr. Management of nipple discharge. World J Surg. 1989;13:736-742.
2. Florio MG, Manganaro T, Pollicino A, et al. Surgical approach to nipple discharge: a ten-year experience. J Surg Oncol. 1999;71:235-238.
3. Gulay H, Bora S, Kilicturgay S, et al. Management of nipple discharge. J Am Coll Surg. 1994;178:471-474.
4. Cabioglu N, Hunt KK, Singletary SE, et al. Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. J Am Coll Surg. 2003;196:354-364.
5. Ito Y, Tamaki Y, Nakano Y, et al. Nonpalpable breast cancer with nipple discharge: how should it be treated? Anticancer Res. 1997;17:791-794.
6. Bauer RL, Eckhert KH Jr., Nemoto T. Ductal carcinoma in situ-associated nipple discharge: a clinical marker for locally extensive disease. Ann Surg Oncol. 1998;5:452-455.
7. Obedian E, Haffty BG. Breast conserving therapy in breast cancer patients presenting with nipple discharge. Int J Radiat Oncol Biol Phys. 2000;47:137-142.
8. Miller NA, Chapman JA, Fish EB, et al. In situ duct carcinoma of the breast: clinical and histopathologic factors and association with recurrent carcinoma. Breast J. 2001;7:292-302.
9. Wertheim U, Ozzello L. Neoplastic involvement of nipple and skin flap in carcinoma of the breast. Am J Surg Pathol. 1980;4:543-549.
10. Kissin MW, Kark AE. Nipple preservation during mastectomy. Br J Surg. 1987;74:58-61.
11. Laronga C, Kemp B, Johnston D, et al. The incidence of occult nipple-areola complex involvement in breast cancer patients receiving a skin-sparing mastectomy. Ann Surg Oncol. 1999;6:609-613.
12. Lambert PA, Kolm P, Perry RR. Parameters that predict nipple involvement in breast cancer. J Am Coll Surg. 2000;191:354-359.
13. Simmons RM, Brennan M, Christos P, et al. Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved? Ann Surg Oncol. 2002;9:165-168.
14. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628-3636.
15. Dietz JR, Crowe JP, Grundfest S, et al. Directed duct excision by using mammary ductoscopy in patients with pathologic nipple discharge. Surgery. 2002;132:582-587; discussion, 587-588.
16. Dooley WC. Routine operative breast endoscopy for bloody nipple discharge. Ann Surg Oncol. 2002;9:920-923.
17. Johnson TL, Kini SR. Cytologic and clinicopathologic features of abnormal nipple secretions: 225 cases. Diagn Cytopathol. 1991;7:17-22.
18. Groves A, Carr M, Wadhera V, et al. An audit of cytology in the evaluation of nipple discharge. A retrospective study of 10 years' experience. Breast. 1996;5:96-99.
19. Dinkel HP, Gassel AM, Muller T, et al. Galactography and exfoliative cytology in women with abnormal nipple discharge. Obstet Gynecol. 2001;97:625-629.
20. Khan SA, Baird C, Staradub VL, et al. Ductal lavage and ductoscopy: the opportunities and the limitations. Clin Breast Cancer. 2002;3:185-191; discussion, 192-195.
21. Krishnamurthy S, Sneige N, Thompson PA, et al. Nipple aspirate fluid cytology in breast carcinoma. Cancer. 2003;99:97-104.
22. Yamamoto D, Senzaki H, Nakagawa H, et al. Detection of chromosomal aneusomy by fluorescence in situ hybridization for patients with nipple discharge. Cancer. 2003;97:690-694.
23. Recht A, Danoff BS, Solin LJ, et al. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. J Clin Oncol. 1985;3:1339-1343.
24. Solin LJ, Kurtz J, Fourquet A, et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol. 1996;14:754-763.
25. Hlawatsch A, Teifke A, Schmidt M, et al. Preoperative assessment of breast cancer: sonography versus MR imaging. AJR Am J Roentgenol. 2002;179:1493-1501.
26. Gerber B, Krause A, Reimer T, et al. Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg. 2003;238:120-127.
27. Friedman EP, Hall-Craggs MA, Mumtaz H, et al. Breast MR and the appearance of the normal and abnormal nipple. Clin Radiol. 1997;52:854-861.
28. Cutuli B, Cohen-Solal-le Nir C, de Lafontan B, et al. Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. Int J Radiat Oncol Biol Phys. 2002;53:868-879.
29. Rodrigues N, Carter D, Dillon D, et al. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2002;54:1331-1335.
30. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16:441-452.
31. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
32. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20:4141-4149.